Overview

A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

Status:
Terminated

Trial end date:
2012-05-01

Target enrollment:
0

Participant gender:
All

Summary

This is a study involving patients who are undergoing allogeneic peripheral blood stem cell transplantation. Both donors and recipients are being sought for this study.

Phase:

Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Emory University

Treatments:

Lenograstim

Criteria

Inclusion Criteria:

- All normal donors for patients undergoing allogeneic peripheral blood stem cell (PBSC)
for hematologic diseases will be invited to participate in this research trial.

- All patients must meet criteria for transplantation.

- Final eligibility will be determined by the health professionals conducting this
clinical trial.

Exclusion Criteria:

- Donors for patients undergoing selected or manipulated PBSC grafts are not eligible.

- Donors who are pregnant or lactating females and donors with a known hypersensitivity
to either G-CSF or GM-CSF will be excluded from this study.

- Final eligibility will be determined by the health professionals conducting this
clinical trial.